TRIM37 and neoplasm: Given that TRIM37 is associated with genomic instability, tumor progression, and poor prognosis (Bhatnagar et al, 2014; Przanowski et al, 2020), we hypothesized that TRIM37 levels in breast tissue could likely inform the clinical outcome.